Japanese

NIKKEI FT Communicable Diseases Conference

The 12th~What new values are required in an age of division?~

NIKKEI FT Communicable Diseases Conference

October7(Tue.) - 9(Thu.)2025

  • Mr. Ryoji NORITAKE

    Mr. Ryoji NORITAKE

  • Mr. Mitsuru MIYATA

    Mr. Mitsuru MIYATA

  • Dr. Shigeru OMI, MD, PhD

    Dr. Shigeru OMI, MD, PhD

  • Nahoko SHINDO,  MD, PhD

    Nahoko SHINDO, MD, PhD

  • Dr. Osamu KUNII,MD, MPH, PhD,

    Dr. Osamu KUNII,MD, MPH, PhD,

  • Prof. Dr. Izuru MAKIHARA

    Prof. Dr. Izuru MAKIHARA

  • Ms. Takuko SAWADA

    Ms. Takuko SAWADA

  • Dr. Yoshihiro TAKAYAMA, MD, PhD

    Dr. Yoshihiro TAKAYAMA, MD, PhD

  • Prof. Yasutoshi KIDO, MD, PhD

    Prof. Yasutoshi KIDO, MD, PhD

  • Ken J. ISHII, M.D., Ph.D.

    Ken J. ISHII, M.D., Ph.D.

  • Isao TESHIROGI, Ph.D.

    Isao TESHIROGI, Ph.D.

  • Manabu SUMI, MD, MPH, PhD

    Manabu SUMI, MD, MPH, PhD

  • Mr. Daikichiro KOBAYASHI

    Mr. Daikichiro KOBAYASHI

  • Dr. Shinichi YAMAGUCHI

    Dr. Shinichi YAMAGUCHI

  • Prof. Fumio OHTAKE

    Prof. Fumio OHTAKE

  • Mikihito TANAKA, Ph.D.

    Mikihito TANAKA, Ph.D.

  • Wataru AKAHATA,PhD

    Wataru AKAHATA,PhD

  • Dr. Yosuke SUNAHARA

    Dr. Yosuke SUNAHARA

  • Seiya KATO, MD, PhD

    Seiya KATO, MD, PhD

  • Prof. KITA Kiyoshi

    Prof. KITA Kiyoshi

  • PhD. Tomonori SASAKI

    PhD. Tomonori SASAKI

  • Prof. Yoko URYUHARA, MBA, PhD

    Prof. Yoko URYUHARA, MBA, PhD

  • Prof. Dr. Fujio TORIUMI

    Prof. Dr. Fujio TORIUMI

  • Mr. Akira MAEMURA

    Mr. Akira MAEMURA

  • Akinori HAMADA, PhD

    Akinori HAMADA, PhD

  • Mr. Yoshiyuki SAGARA

    Mr. Yoshiyuki SAGARA

  • Mr. Toshiaki NAGASATO

    Mr. Toshiaki NAGASATO

  • Ms. Asuka MIYABASHIRA

    Ms. Asuka MIYABASHIRA

  • Mr. Tetsuya KASHIHARA

    Mr. Tetsuya KASHIHARA

  • Masayuki YABUTA, Ph.D.

    Masayuki YABUTA, Ph.D.

  • Dr.Ataru IGARASHI,PhD

    Dr.Ataru IGARASHI,PhD

  • Dr. Takaji WAKITA, M.D.,Ph.D.

    Dr. Takaji WAKITA, M.D.,Ph.D.

  • Mr.NAOYA HORIUCHI

    Mr.NAOYA HORIUCHI

  • Dr. Masanari MINAMITANI, MD, PhD

    Dr. Masanari MINAMITANI, MD, PhD

  • Prof.hiroshi NAKANISHI

    Prof.hiroshi NAKANISHI

  • Prof. Kazuhiro NAKAYAMA

    Prof. Kazuhiro NAKAYAMA

  • Yukio NISHIGUCHI,MD

    Yukio NISHIGUCHI,MD

  • Wataru SUGIURA M.D., Ph.D.

    Wataru SUGIURA M.D., Ph.D.

  • Prof. Kei MIKITA, M.D., Ph.D.

    Prof. Kei MIKITA, M.D., Ph.D.

  • Dr. Hiroki SAITO, MD PhD MPH

    Dr. Hiroki SAITO, MD PhD MPH

  • Ms. Yui KOHNO

    Ms. Yui KOHNO

  • Prof.KOKI KAKU, MD, PhD

    Prof.KOKI KAKU, MD, PhD

  • Kazuhiro NAGATA,PhD

    Kazuhiro NAGATA,PhD

  • Dr. Kayo ITO, MD, MPH

    Dr. Kayo ITO, MD, MPH

  • D. Sc. Elina HENTTONEN

    D. Sc. Elina HENTTONEN

  • Dr. Ashish K. JHA, MD, MPH

    Dr. Ashish K. JHA, MD, MPH

  • Dr. KITA Yosuke

    Dr. KITA Yosuke

  • Prof. Dr. Takashi NAKANO, MD, PhD

    Prof. Dr. Takashi NAKANO, MD, PhD

  • Dr. Tomoya SAITO, MD, MPH, PhD

    Dr. Tomoya SAITO, MD, MPH, PhD

  • Prof. Kayo TAKUMA

    Prof. Kayo TAKUMA

  • SUZUKI,Yasuhiro M.D.,Ph.D,MPH,MSc

    SUZUKI,Yasuhiro M.D.,Ph.D,MPH,MSc

  • Ms.Emi ONOSAKA

    Ms.Emi ONOSAKA

  • Kozo AKINO, MD

    Kozo AKINO, MD

  • Prof. Dr. Shigeyuki KANO , MD, PhD

    Prof. Dr. Shigeyuki KANO , MD, PhD

  • Eiji HINOSHITA, MD, PhD, MSc

    Eiji HINOSHITA, MD, PhD, MSc

  • Dr. Elizabeth KATWESIGYE

    Dr. Elizabeth KATWESIGYE

  • Mr. Yoshihide HIRUTA

    Mr. Yoshihide HIRUTA

  • Mr.Kennet BRYSTING

    Mr.Kennet BRYSTING

  • Mr.Tsuyoshi YURITA

    Mr.Tsuyoshi YURITA

  • Prof. Noboru MINAKAWA Ph.D.

    Prof. Noboru MINAKAWA Ph.D.

  • Prof. Dr. Martin HEIDECKER PhD, MBA

    Prof. Dr. Martin HEIDECKER PhD, MBA

  • Dr.Ayako TAKEMI

    Dr.Ayako TAKEMI

  • Keishi ABE, M.D.

    Keishi ABE, M.D.

  • Ms. Emma NYAWERE

    Ms. Emma NYAWERE

  • Mr.Michael PEEL

    Mr.Michael PEEL

  • Prof. Masaaki KITAJIMA, PhD

    Prof. Masaaki KITAJIMA, PhD

  • Mr. Kiyotaka EGUCHI

    Mr. Kiyotaka EGUCHI

  • Dr.Hayato URABE, PhD, MPIA

    Dr.Hayato URABE, PhD, MPIA

  • Daisuke FUJIWARA Ph., D.

    Daisuke FUJIWARA Ph., D.

  • Mr. Keizo TAKEMI

    Mr. Keizo TAKEMI

  • Mr. Rahul DWIVEDI

    Mr. Rahul DWIVEDI

  • Dr. Hirobumi NIKI, MD, PhD

    Dr. Hirobumi NIKI, MD, PhD

  • Dr. Ute STRÖHER, PhD

    Dr. Ute STRÖHER, PhD

  • Dr Tedros Adhanom GHEBREYESUS

    Dr Tedros Adhanom GHEBREYESUS

  • Dr. Nikki ROMANIK

    Dr. Nikki ROMANIK

Lecturers

A

  • Keishi ABE, M.D.
    Agenda1 Special Session2

    Keishi ABE, M.D.

    Member of the House of Representatives, Japan

    Nippon Ishin (Japan Innovation Party)

  • Wataru AKAHATA,PhD
    Agenda2

    Wataru AKAHATA,PhD

    Founder, CEO, and Chief R&D Officer

    VLP Therapeutics Japan, Inc.

  • Kozo AKINO, MD
    Special Session5

    Kozo AKINO, MD

    Member of The House of Councillors, National Diet of Japan, District of Fukuoka Prefecture

  • Dr. Ashish K. JHA, MD, MPH
    Keynote Speech

    Dr. Ashish K. JHA, MD, MPH

    Dean, Brown University School of Public Health, USA

B

  • Mr.Kennet BRYSTING
    Special Session2

    Mr.Kennet BRYSTING

    President and Representative Director of Gilead Sciences K.K.

D

  • Mr. Rahul DWIVEDI
    Special Session4

    Mr. Rahul DWIVEDI

    Access Leader - Serious Bacterial Infections, GARDP

E

  • Mr. Kiyotaka EGUCHI
    Agenda4

    Mr. Kiyotaka EGUCHI

    Senior Manager, Head of Social Action Promotion Office, Chairperson Office, LY Corporation

    Chief Information Officer and Chief Data Officer, Kanagawa Prefectural Government

F

  • Daisuke FUJIWARA Ph., D.
    Organizer session

    Daisuke FUJIWARA Ph., D.

    Senior Executive Officer, President of R&D Division, Kirin Holdings Co., Ltd.

G

  • Dr Tedros Adhanom GHEBREYESUS
    Opening Message

    Dr Tedros Adhanom GHEBREYESUS

    Director-General

    World Health Organization

H

  • Akinori HAMADA, PhD
    Agenda4

    Akinori HAMADA, PhD

    Associate Professor

    (Department of Interdisciplinary Cultural Studies, Graduate School of Arts and Sciences, the University of Tokyo)

  • Prof. Dr. Martin HEIDECKER PhD, MBA
    Special Session4

    Prof. Dr. Martin HEIDECKER PhD, MBA

    Chief Investment Officer

    AMR Action Fund

  • D. Sc. Elina HENTTONEN
    Agenda4

    D. Sc. Elina HENTTONEN

    CEO , Valtaamo Oy/Ltd

  • Eiji HINOSHITA, MD, PhD, MSc
    Agenda1

    Eiji HINOSHITA, MD, PhD, MSc

    Director General for Health and Medicine, Ministry of Defense

  • Mr. Yoshihide HIRUTA
    Agenda2

    Mr. Yoshihide HIRUTA

    General Manager, External Relations on International Cooperation, Business Development

    Sysmex Corporation

  • Mr.NAOYA HORIUCHI
    Agenda2 Special Session3

    Mr.NAOYA HORIUCHI

    Counsellor (National Healthcare Policy Secretariat / Cabinet Office)

I

  • Dr.Ataru IGARASHI,PhD
    Special Session5

    Dr.Ataru IGARASHI,PhD

    Dept.of Health Policy and Public Health

    Graduate School of Pharmaceutical Sciences,

    The University of Tokyo

  • Ken J. ISHII, M.D., Ph.D.
    Agenda2

    Ken J. ISHII, M.D., Ph.D.

    Professor,

    Division of Vaccine Science, Department of Microbiology and Immunology

    The Institute of Medical Science, The University of Tokyo

  • Dr. Kayo ITO, MD, MPH
    Agenda2

    Dr. Kayo ITO, MD, MPH

    Director / Department of Infectious Disease Research / Japan Agency for Medical Research and Development

K

  • Prof.KOKI KAKU, MD, PhD
    Agenda3

    Prof.KOKI KAKU, MD, PhD

    National Defense Medical College Research Institue, Director

  • Prof. Dr. Shigeyuki KANO , MD, PhD
    Special Session6

    Prof. Dr. Shigeyuki KANO , MD, PhD

    Director, Department of Tropical Medicine and Malaria, National Insitute of Global Health and Medicine, Japan Institute for Health Security (JIHS)

  • Seiya KATO, MD, PhD
    Agenda2

    Seiya KATO, MD, PhD

    Director,

    Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA)

  • Mr. Tetsuya KASHIHARA
    Special Session7

    Mr. Tetsuya KASHIHARA

    Director, Health Education and Shokuiku Division

    Education Policy Bureau

    Ministry of Education, Culture, Sports, Science and Technology (MEXT)

  • Dr. Elizabeth KATWESIGYE
    Special Session1

    Dr. Elizabeth KATWESIGYE

    MBChB, MMed, IPC Specialist, Ministry of Health - Republic of uganda

  • Prof. Yasutoshi KIDO, MD, PhD
    Agenda2

    Prof. Yasutoshi KIDO, MD, PhD

    Dept. of Virology/Parasitology, Grad. Scl. Od Med., Osaka Metropolitan University

  • Prof. KITA Kiyoshi
    Agenda2 Conclusion

    Prof. KITA Kiyoshi

    Dean and Professor,

    School of Tropical Medicine and Global Health,

    Nagasaki University

    The University of Tokyo, Professor Emeritus

  • Dr. KITA Yosuke
    Agenda3

    Dr. KITA Yosuke

    Director, Global Health Strategy Division, Ministry of Foreign Affairs, Government of Japan

  • Prof. Masaaki KITAJIMA, PhD
    Agenda1

    Prof. Masaaki KITAJIMA, PhD

    Laboratory of International Wastewater-based Epidemiology, School of Engineering, The University of Tokyo

  • Mr. Daikichiro KOBAYASHI
    Agenda4

    Mr. Daikichiro KOBAYASHI

    Chairman and Representative Director

    Meiji Seika Pharma Co., Ltd.

  • Ms. Yui KOHNO
    Special Session3 Agenda2 - Summary

    Ms. Yui KOHNO

    Manager, Health and Global Policy Institute (HGPI)

  • Mr. Michikazu KOSHIBA
    Agenda4 Special Session7 Agenda4 - Summary Conclusion

    Mr. Michikazu KOSHIBA

    Director – Healthcare / Well-being,

    Advisory Services Division, Public Sector Advirosy, KPMG AZSA LLC

  • Dr. Osamu KUNII,MD, MPH, PhD,
    Agenda2 Agenda2 - Summary

    Dr. Osamu KUNII,MD, MPH, PhD,

    CEO and Executive Director, GHIT Fund

M

  • Mr. Akira MAEMURA
    Agenda4 Conclusion

    Mr. Akira MAEMURA

    Commentary Center/Editorial Division/Nikkei Inc.

  • Prof. Dr. Izuru MAKIHARA
    Agenda3 Conclusion

    Prof. Dr. Izuru MAKIHARA

    Professor

    Research Center for Advanced Science and Technology, University of Tokyo

  • Prof. Kei MIKITA, M.D., Ph.D.
    Agenda1

    Prof. Kei MIKITA, M.D., Ph.D.

    Department of Global Infectious Diseases and Tropical Medicine, National Defense Medical College, Professor

  • Prof. Noboru MINAKAWA Ph.D.
    Special Session6 Conclusion

    Prof. Noboru MINAKAWA Ph.D.

    Institute of Tropical Medicine, Nagasaki University

    Professor

  • Dr. Masanari MINAMITANI, MD, PhD
    Special Session7

    Dr. Masanari MINAMITANI, MD, PhD

    Department of Radiology, The University of Tokyo Hospital/ Assistant Professor

    Association for Cancer Education by Medical Students/ Co-Chairperson

  • Ms.Asuka MIYABASHIRA
    Special Session3

    Ms.Asuka MIYABASHIRA

    President of Japan Pharmaceutical Manufacturers Association

  • Mr. Mitsuru MIYATA
    Introduction Agenda1 Agenda2 Agenda2 - Summary Special Session5 Agenda3 Agenda4 Special Session8 Agenda4 - Summary Conclusion

    Mr. Mitsuru MIYATA

    CEO

    Miyata Institute of Technologies,K.K.

N

  • Mr. Toshiaki NAGASATO
    Special Session8 Agenda4 - Summary

    Mr. Toshiaki NAGASATO

    President and Representative Director Meiji Seika Pharma Co., Ltd.

    Chairman and Representative Director KM Biologics Co.,Ltd.

  • Kazuhiro NAGATA,PhD
    Special Lecture Agenda4

    Kazuhiro NAGATA,PhD

    Director General

    JT Biohistory Research Hall

  • Prof.hiroshi NAKANISHI
    Agenda3

    Prof.hiroshi NAKANISHI

    School of Government, Kyoto University

  • Prof. Dr. Takashi NAKANO, MD, PhD
    Special Session5

    Prof. Dr. Takashi NAKANO, MD, PhD

    Department of Pediatrics, Kawasaki Medical School

  • Prof. Kazuhiro NAKAYAMA
    Special Session7

    Prof. Kazuhiro NAKAYAMA

    Department of Nursing Informatics, Graduate School of Nursing Science, St. Luke’s International University

  • Dr. Hirobumi NIKI, MD, PhD
    Special Session2

    Dr. Hirobumi NIKI, MD, PhD

    State Minister of Health, Labour and Welfare

    Member of the House of Representatives, Japan

    Liberal Democratic Party

  • Yukio NISHIGUCHI,MD
    Agenda3

    Yukio NISHIGUCHI,MD

    Director of Osaka City General Hospital

  • Mr. Ryoji NORITAKE
    Agenda1 Special Session2 Special Session4 Agenda2 - Summary Conclusion

    Mr. Ryoji NORITAKE

    Chair Health and Global Policy Institute (HGPI)

  • Ms. Emma NYAWERE
    Special Session1

    Ms. Emma NYAWERE

    Senior Hygiene Instractor, Saraya Manufacturing (U) Ltd.

O

  • Prof. Fumio OHTAKE
    Agenda3 Agenda4 Conclusion

    Prof. Fumio OHTAKE

    Specially Appointed Professor

    Center for Infectious Disease Education and Research (CiDER), Osaka University

  • Dr. Shigeru OMI, MD, PhD
    Introduction Agenda1 Agenda2 Agenda2 - Summary Agenda3 Agenda4 Agenda4 - Summary Conclusion

    Dr. Shigeru OMI, MD, PhD

    Japan Anti-Tuberculosis Association, Chairman, Representative,Board of Director

    World Health Organization (WHO), Regional Office for Western Pacific

  • Ms.Emi ONOSAKA
    Special Session1

    Ms.Emi ONOSAKA

    Consultant, International Techno Center Co., Ltd

P

  • Mr.Michael PEEL
    Agenda1 Conclusion

    Mr.Michael PEEL

    Science Editor Financial Times

R

  • Dr. Nikki ROMANIK
    Agenda1

    Dr. Nikki ROMANIK

    Distinguished Senior Fellow, Global Health Security, Brown University School of Public Health

S

  • Mr. Yoshiyuki SAGARA
    Agenda1

    Mr. Yoshiyuki SAGARA

    Senior Research Fellow, Institute of Geoeconomics (IOG), The International House of Japan

  • Dr. Hiroki SAITO, MD PhD MPH
    Special Session1

    Dr. Hiroki SAITO, MD PhD MPH

    Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine

  • Dr. Tomoya SAITO, MD, MPH, PhD
    Agenda1

    Dr. Tomoya SAITO, MD, MPH, PhD

    Director, Department of Intelligence and Emergency Operations, Bureau of Health Security and Management, Japan Institute for Health Security

  • PhD. Tomonori SASAKI
    Special Session6

    PhD. Tomonori SASAKI

    Fumakilla LIMITED / Research & Development division /

    Fundamental Science research department / Department manager

  • Ms. Takuko SAWADA
    Agenda1 Agenda2 Special Session4

    Ms. Takuko SAWADA

    Vice-Chair,

    Shionogi & Co., Ltd.

  • Nahoko SHINDO,  MD, PhD
    Agenda1 Agenda2 Agenda2 - Summary Agenda3 Organizer session Agenda4 Agenda4 - Summary Conclusion

    Nahoko SHINDO, MD, PhD

    Unit Head, Bio-risk management and Biosafety

    Epidemic and Pandemic Threat Management

    WHO Health Emergencies Programme

  • Dr. Ute STRÖHER, PhD
    Agenda2

    Dr. Ute STRÖHER, PhD

    Regulation and Prequalification Department / World Health Organization

  • Wataru SUGIURA M.D., Ph.D.
    Special Session2

    Wataru SUGIURA M.D., Ph.D.

    Director General

    Center for Clinical Sciences

    Japan Institute for Health Security

  • Manabu SUMI, MD, MPH, PhD
    Agenda2 Special Session4

    Manabu SUMI, MD, MPH, PhD

    Director-General

    Department of Infectious Disease Prevention and Control

    Ministry of Health, Labour and Welfare

  • Dr. Yosuke SUNAHARA
    Agenda3 Conclusion

    Dr. Yosuke SUNAHARA

    Kobe University

    Graduate School of Law

  • SUZUKI,Yasuhiro M.D.,Ph.D,MPH,MSc
    Special Session2

    SUZUKI,Yasuhiro M.D.,Ph.D,MPH,MSc

    President

    International University of Health & Welfare

T

  • Dr. Yoshihiro TAKAYAMA, MD, PhD
    Agenda3

    Dr. Yoshihiro TAKAYAMA, MD, PhD

    Deputy director

    Division of Infectious Diseases

    Okinawa Chubu Hospital

  • Dr.Ayako TAKEMI
    Agenda1

    Dr.Ayako TAKEMI

    Associate Professor, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo

  • Mr. Keizo TAKEMI
    Special Session2 General Overview

    Mr. Keizo TAKEMI

    Former Minister of Health, Labour and Welfare

    Japan Center for International Exchange Senior Fellow

    Chair of the Asian Population and Development Association (APDA)

  • Prof. Kayo TAKUMA
    Agenda1

    Prof. Kayo TAKUMA

    Professor, Faculty of Law, Keio University

  • Mikihito TANAKA, Ph.D.
    Agenda4 Conclusion

    Mikihito TANAKA, Ph.D.

    Professor, Faculty of Political Science and Economics, Waseda University

  • Isao TESHIROGI, Ph.D.
    Agenda3

    Isao TESHIROGI, Ph.D.

    Chief Executive Officer

    Shionogi & Co., Ltd.

  • Prof. Dr. Fujio TORIUMI
    Special Session8

    Prof. Dr. Fujio TORIUMI

    Graduate School of Engineer, The University of Tokyo

U

  • Dr.Hayato URABE, PhD, MPIA
    Organizer session

    Dr.Hayato URABE, PhD, MPIA

    Associate Vice President, Investment for Impact

    Global Health Innovative Technology Fund (GHIT Fund)

  • Prof. Yoko URYUHARA, MBA, PhD
    Agenda4

    Prof. Yoko URYUHARA, MBA, PhD

    Professor,

    Faculty of Commerce, Doshisha University Director, Social Marketing Research Centre

W

  • Dr. Takaji WAKITA, M.D.,Ph.D.
    Agenda2 Agenda3 Agenda4

    Dr. Takaji WAKITA, M.D.,Ph.D.

    Vice President of the Japan Institute for Health Security (JIHS)

Y

  • Masayuki YABUTA, Ph.D.
    Special Session3

    Masayuki YABUTA, Ph.D.

    Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA)

    Japan Agency for Medical Research and Development

  • Dr. Shinichi YAMAGUCHI
    Agenda4

    Dr. Shinichi YAMAGUCHI

    Associate Professor, Center for Global Communications (GLOCOM),

    International University of Japan

  • Mr.Tsuyoshi YURITA
    Special Session5

    Mr.Tsuyoshi YURITA

    Takeda Pharmaceutical Company Limited

    Business Unit 1, Japan Pharma Business Unit

Organizer

  • NIKKEI

Co-organizer

  • THE FINANCIAL TIMES LTD

Sponsors

  • The Japan Pharmaceutical Manufacturers Association (JPMA)
  • Gilead Sciences K.K.
  • Global Health Innovative Technology Fund(GHIT Fund)
  • Saraya Co., Ltd.
  • SHIONOGI
  • sysmex
  • Takeda Pharmaceutical Company Limited
  • BIKEN
  • FUMAKILLA Limited
  • Meiji Seika Pharma Co., Ltd.
  • KM Biologics Co.,Ltd.